Cheon et al. [80] assessed the usefulness of serum IL-6 in bile duct cancer patients receiving photodynamic therapy (14 of the 26 patients), matching pre-therapy and post-therapy IL-6 levels to the tumor size. This evidence concerns the gene IL6 and neoplasm.